Abstract
Developing, manufacturing and marketing innovative new pharmaceutical drugs is
highly complex and involves significant investment. Establishing an acceptable
return on investment requires generating sufficient sales revenues which in
turn requires maximizing market access at the highest possible price.
View Cart
